Fidelity Investments’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Fidelity Investments’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,696	Closed	-$14.4K	–	5840
2023 Q4	$14.4K	Buy	5,696 +1,967	+53%	+$4.58K	﹤0.01%	4108
2023 Q3	$8.91K	Sell	3,729 -782	-17%	-$1.73K	﹤0.01%	4149
2023 Q2	$10.4K	Sell	4,511 -1,064	-19%	-$3K	﹤0.01%	4121
2023 Q1	$14.2K	Buy	5,575 +1,812	+48%	+$5.19K	﹤0.01%	3989
2022 Q4	$9.45K	Buy	3,763 +1,435	+62%	+$4K	﹤0.01%	4034
2022 Q3	$7K	Buy	2,328 +1,664	+251%	+$7K	﹤0.01%	4224
2022 Q2	$3K	Buy	+664	New	+$3.95K	﹤0.01%	4512

Fidelity Investments's SLGC Position: Q1 2024 in Review

Fidelity Investments sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 5,696 shares — an estimated $14.4K sold.

Fidelity Investments first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $14.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Fidelity Investments reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 5,696 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $14.4K.
Fidelity Investments first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Fidelity Investments's SomaLogic, Inc. Class A Common Stock position peaked at $14.4K in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.